March 2020 - Page 42 of 342

Canadian Stock Exchange News - March 30, 2020

REPEAT – CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI

VANCOUVER, British Columbia, March 30, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) […]

Canadian Stock Exchange News - March 30, 2020

RAPPEL – Champignon Brands élargit son portefeuille d’études précliniques grâce à des études mesurées de dosage de psilocybine à l’Université de Miami

VANCOUVER, Colombie-Britannique, 30 mars 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTC : […]

TSX Venture News - March 30, 2020

U3O8 Corp. Announces the Termination of the Binding Letter of Intent with Diagnostic Lab Corporation, Inc. and Postpones Reporting of Fourth Quarter and 2019 Full-Year Reporting Due to Delays Caused by COVID-19 Pandemic

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — U3O8 Corp. (NEX: UWE.H), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that, further […]

NASDAQ Companies - March 30, 2020

Zealand Pharma announces positive topline results from Phase 2 trial with dasiglucagon in individuals who have undergone bariatric surgery

Company announcement – No. 10 / 2020Zealand Pharma announces positive topline results from Phase 2 trial with dasiglucagon in individuals […]

NASDAQ Companies - March 30, 2020

REPEAT – CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI

RAPPEL – Champignon Brands élargit son portefeuille d’études précliniques grâce à des études mesurées de dosage de psilocybine à l’Université de Miami

U3O8 Corp. Announces the Termination of the Binding Letter of Intent with Diagnostic Lab Corporation, Inc. and Postpones Reporting of Fourth Quarter and 2019 Full-Year Reporting Due to Delays Caused by COVID-19 Pandemic

Zealand Pharma announces positive topline results from Phase 2 trial with dasiglucagon in individuals who have undergone bariatric surgery

Neuronetics Recognized as 2020 Top Neurology Device Provider

Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual

MUSCLE MAKER GRILL CONTINUES BRAND EXPANSION EFFORTS WITH NEW LOCATION OPENING AT U.S. MARINE CORPS CAMP ELMORE

Pluristem Treated First Three COVID-19 Patients in Israel under Compassionate Use

MediWound Provides Corporate Update Related to COVID-19 Pandemic

Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights